Michelle P Debbink1,2, Torri D Metz1,2, Richard E Nelson3,4, Sophie E Janes5, Alexandra Kroes5, Lori J Begaye6, Cara C Heuser2, Marcela C Smid1,2, Robert M Silver1, Michael W Varner1,2, Brett D Einerson1,2. 1. Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, Utah. 2. Division of Maternal-Fetal Medicine, Women and Newborns Clinical Program, Intermountain Healthcare, Salt Lake City, Utah. 3. Division of Epidemiology, Department of Internal Medicine, University of Utah Health, Salt Lake City, Utah. 4. Division of Pediatric Administration, Department of Pediatrics, University of Utah Health, Salt Lake City, Utah. 5. University of Utah School of Medicine, University of Utah Health, Salt Lake City, Utah. 6. Department of International Studies, University of Utah, Salt Lake City, Utah.
Abstract
OBJECTIVE: To estimate the actual excess costs of care for delivery admissions complicated by severe maternal morbidity (SMM) compared with uncomplicated deliveries. STUDY DESIGN: This is a retrospective cohort study of all deliveries between October 2015 and September 2018 at a single tertiary academic center. Pregnant individuals ≥ 20 weeks' gestation who delivered during a hospital admission (i.e., a "delivery admission") were included. The primary exposure was SMM, as defined by Centers for Disease Control and Prevention (CDC) criteria, CDC criteria excluding blood transfusion, or by validated hospital-defined criteria (intensive care unit admission or ≥ 4 units of blood products). Potential SMM events identified via administrative and blood bank data were reviewed to confirm SMM events had occurred. Primary outcome was total actual costs of delivery admission derived from time-based accounting and acquisition costs in the institutional Value Driven Outcomes database. Cost of delivery admissions with SMM events was compared with the cost of uncomplicated delivery using adjusted generalized linear models, with separate models for each of the SMM definitions. Relative cost differences are reported due to data restrictions. RESULTS: Of 12,367 eligible individuals, 12,361 had complete cost data. Two hundred and eighty individuals (2.3%) had confirmed SMM events meeting CDC criteria. CDC criteria excluding transfusion alone occurred in 1.0% (n = 121) and hospital-defined SMM in 0.6% (n = 76). In adjusted models, SMM events by CDC criteria were associated with a relative cost increase of 2.45 times (95% confidence interval [CI]: 2.29-2.61) the cost of an uncomplicated delivery. SMM by CDC criteria excluding transfusion alone was associated with a relative increase of 3.26 (95% CI: 2.95-3.60) and hospital-defined SMM with a 4.19-fold (95% CI: 3.64-4.83) increase. Each additional CDC subcategory of SMM diagnoses conferred a relative cost increase of 1.60 (95% CI: 1.43-1.79). CONCLUSION: SMM is associated with between 2.5- and 4-fold higher cost than uncomplicated deliveries. KEY POINTS: · Severe maternal morbidity as defined by CDC criteria confers a 2.5-fold increase in delivery hospitalization costs.. · Intensive care unit admission or ≥ 4 units of blood products confer a fourfold increase in cost.. · Costs of maternal morbidity may motivate SMM review.. Thieme. All rights reserved.
OBJECTIVE: To estimate the actual excess costs of care for delivery admissions complicated by severe maternal morbidity (SMM) compared with uncomplicated deliveries. STUDY DESIGN: This is a retrospective cohort study of all deliveries between October 2015 and September 2018 at a single tertiary academic center. Pregnant individuals ≥ 20 weeks' gestation who delivered during a hospital admission (i.e., a "delivery admission") were included. The primary exposure was SMM, as defined by Centers for Disease Control and Prevention (CDC) criteria, CDC criteria excluding blood transfusion, or by validated hospital-defined criteria (intensive care unit admission or ≥ 4 units of blood products). Potential SMM events identified via administrative and blood bank data were reviewed to confirm SMM events had occurred. Primary outcome was total actual costs of delivery admission derived from time-based accounting and acquisition costs in the institutional Value Driven Outcomes database. Cost of delivery admissions with SMM events was compared with the cost of uncomplicated delivery using adjusted generalized linear models, with separate models for each of the SMM definitions. Relative cost differences are reported due to data restrictions. RESULTS: Of 12,367 eligible individuals, 12,361 had complete cost data. Two hundred and eighty individuals (2.3%) had confirmed SMM events meeting CDC criteria. CDC criteria excluding transfusion alone occurred in 1.0% (n = 121) and hospital-defined SMM in 0.6% (n = 76). In adjusted models, SMM events by CDC criteria were associated with a relative cost increase of 2.45 times (95% confidence interval [CI]: 2.29-2.61) the cost of an uncomplicated delivery. SMM by CDC criteria excluding transfusion alone was associated with a relative increase of 3.26 (95% CI: 2.95-3.60) and hospital-defined SMM with a 4.19-fold (95% CI: 3.64-4.83) increase. Each additional CDC subcategory of SMM diagnoses conferred a relative cost increase of 1.60 (95% CI: 1.43-1.79). CONCLUSION: SMM is associated with between 2.5- and 4-fold higher cost than uncomplicated deliveries. KEY POINTS: · Severe maternal morbidity as defined by CDC criteria confers a 2.5-fold increase in delivery hospitalization costs.. · Intensive care unit admission or ≥ 4 units of blood products confer a fourfold increase in cost.. · Costs of maternal morbidity may motivate SMM review.. Thieme. All rights reserved.
Authors: Beverley Lawton; Evelyn Jane MacDonald; Selina Ann Brown; Leona Wilson; James Stanley; John David Tait; Richard Alan Dinsdale; Carolyn Lee Coles; Stacie E Geller Journal: Am J Obstet Gynecol Date: 2014-02-06 Impact factor: 8.661
Authors: Beverley A Lawton; E Jane MacDonald; James Stanley; Karen Daniells; Stacie E Geller Journal: Acta Obstet Gynecol Scand Date: 2019-01-28 Impact factor: 3.636
Authors: Jeremy D Meier; Melanie Duval; Jacob Wilkes; Seth Andrews; E Kent Korgenski; Albert H Park; Rajendu Srivastava Journal: Otolaryngol Head Neck Surg Date: 2014-02-13 Impact factor: 3.497
Authors: Kimberly K Vesco; Shannon Ferrante; Yong Chen; Thomas Rhodes; Christopher M Black; Felicia Allen-Ramey Journal: Matern Child Health J Date: 2020-01
Authors: Kensaku Kawamoto; Cary J Martin; Kip Williams; Ming-Chieh Tu; Charlton G Park; Cheri Hunter; Catherine J Staes; Bruce E Bray; Vikrant G Deshmukh; Reid A Holbrook; Scott J Morris; Matthew B Fedderson; Amy Sletta; James Turnbull; Sean J Mulvihill; Gordon L Crabtree; David E Entwistle; Quinn L McKenna; Michael B Strong; Robert C Pendleton; Vivian S Lee Journal: J Am Med Inform Assoc Date: 2014-10-16 Impact factor: 4.497
Authors: Brett D Einerson; Richard E Nelson; Grecio Sandoval; M Sean Esplin; D Ware Branch; Torri D Metz; Robert M Silver; William A Grobman; Uma M Reddy; Michael Varner Journal: Obstet Gynecol Date: 2020-07 Impact factor: 7.623